NCT05664971 JS004 Combined With Toripalimab and With Standard Chemotherapy Treat Patients With Advanced Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT05659381 Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer Status RECRUITING Phase PHASE3
NCT05640791 Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT05637268 Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT05635708 A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05633667 Study of Novel Treatment Combinations in Patients With Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05624996 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer Status RECRUITING Phase PHASE3
NCT05615818 Personalized Medicine for Advanced Biliary Cancer Patients Status RECRUITING Phase PHASE3
NCT05608369 Vorinostat in Combination With Chemoradiation in Locally Advanced HPV Negative HNSCC Status WITHDRAWN Phase PHASE2
NCT05599984 Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05596890 Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients Status UNKNOWN Phase PHASE2
NCT05594290 Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05587374 Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05577702 Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT05576272 A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05570422 A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 Status RECRUITING Phase PHASE1
NCT05555732 Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05541016 De-Escalated Adjuvant and Definitive Radiation Therapy Informed by DART 2.0 ctHPV-DNA Status RECRUITING Phase PHASE2